
Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 844 | 880 | 1134 | 1848 | 3389 | - |
Fund Return | -15.64% | -12% | 13.37% | 22.72% | 27.65% | - |
Place in category | 67 | 38 | 9 | 4 | 1 | - |
% in Category | 76 | 55 | 11 | 4 | 1 | - |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
ICICI Focused Bluechip Equity RetGr | 632.97B | -7.18 | 14.76 | 12.23 | ||
ICICI Focused Bluechip Eq RetailDiv | 632.97B | -14.86 | 10.98 | 10.55 | ||
ICICI Prud Focused Bluechip Div | 632.97B | -11.16 | 13.57 | 12.24 | ||
ICICI Prud Focused Bluechip Gr | 632.97B | -7.10 | 15.45 | 13.07 | ||
ICICI Balanced Adv Dir Div | 604.34B | -2.94 | 11.30 | 10.69 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Reliance Pharma Fund - Bonus | 81.61B | -14.28 | 17.38 | 13.51 | ||
Reliance Pharma Dividend Payout | 81.61B | -14.99 | 16.77 | 14.45 | ||
Reliance Pharma Fund - Growth | 81.61B | -14.28 | 17.38 | 13.51 | ||
Reliance Pharma Direct Bonus | 81.61B | -14.16 | 18.44 | 14.52 | ||
Reliance Pharma Direct Growth | 81.61B | -14.16 | 18.44 | 14.52 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Sun Pharma | INE044A01036 | 13.56 | 1,683.45 | +0.39% | |
Cipla | INE059A01026 | 9.71 | 1,461.90 | +0.52% | |
Dr Reddy’s Laboratories | INE089A01031 | 8.28 | 1,107.95 | +0.25% | |
Divi's Labs | INE361B01024 | 6.05 | 5,620.45 | -0.82% | |
Aurobindo Pharma | INE406A01037 | 4.87 | 1,094.75 | -1.19% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Strong Sell | Sell | Buy |
Technical Indicators | Sell | Strong Sell | Strong Buy |
Summary | Strong Sell | Strong Sell | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review